Fig. 3.
Representative MR images of (a) control (no eye treatment), (b) at 50 min after passive delivery (passive control), and (c) at 45 min, 2.5 h, 12.5 h, and 14.5 h, from left to right, respectively, after 20-min 4-mA transscleral iontophoresis of Galbumin™ (concentration in the device ≈ 100 mg/ml) in vivo.